Stuttgart - Delayed Quote EUR
Telix Pharmaceuticals Ltd (T3X.SG)
16.16
+2.45
+(17.91%)
At close: April 23 at 1:11:11 PM GMT+2
Loading Chart for T3X.SG
- Previous Close
13.70 - Open
15.61 - Bid 15.61 x --
- Ask 16.12 x --
- Day's Range
15.61 - 16.16 - 52 Week Range
9.75 - 24.60 - Volume
500 - Avg. Volume
1,685 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 20, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: T3X.SG
View MorePerformance Overview: T3X.SG
Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
T3X.SG
12.30%
S&P/ASX 200 [XJO] (^AXJO)
2.50%
1-Year Return
T3X.SG
65.74%
S&P/ASX 200 [XJO] (^AXJO)
3.54%
3-Year Return
T3X.SG
65.74%
S&P/ASX 200 [XJO] (^AXJO)
6.45%
5-Year Return
T3X.SG
65.74%
S&P/ASX 200 [XJO] (^AXJO)
51.74%
Compare To: T3X.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: T3X.SG
View MoreValuation Measures
As of 4/22/2025
Market Cap
4.70B
Enterprise Value
4.63B
Trailing P/E
169.90
Forward P/E
54.64
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.83
Price/Book (mrq)
14.47
Enterprise Value/Revenue
10.60
Enterprise Value/EBITDA
89.68
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--